Victory Capital Management Inc Castle Biosciences Inc Transaction History

Victory Capital Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$22.51 - $34.32 $17,602 - $26,838	-782 Reduced 2.96%	25,637 $669,000
Q2 2022 Aug 01, 2022	BUY	$16.0 - $45.99 $1,488 - $4,277	93 Added 0.35%	26,419 $580,000
Q1 2022 May 04, 2022	SELL	$33.17 - $46.98 $138,915 - $196,752	-4,188 Reduced 13.72%	26,326 $588,000
Q4 2021 Feb 07, 2022	SELL	$39.06 - $67.58 $11.3 Million - $19.5 Million	-289,145 Reduced 90.45%	30,514 $1.31 Million
Q3 2021 Nov 02, 2021	BUY	$60.13 - $77.6 $685,602 - $884,795	11,402 Added 3.7%	319,659 $21.3 Million

Q2 2021 Aug 03, 2021	SELL	$50.07 - $76.78 $3.93 Million - $6.03 Million	-78,528 Reduced 20.3%	308,257 $22.6 Million
Q1 2021 May 04, 2021	BUY	$58.92 - $97.33 $1.59 Million - $2.62 Million	26,918 Added 7.48%	386,785 $26.5 Million
Q4 2020 Feb 01, 2021	BUY	$43.6 - $73.05 $14.9 Million - $24.9 Million	340,767 Added 1784.12%	359,867 $24.2 Million
Q3 2020 Nov 09, 2020	SELL	$38.47 - $52.03 $145,916 - $197,349	-3,793 Reduced 16.57%	19,100 $983,000
Q2 2020 Aug 07, 2020	BUY	$27.28 - $43.01 $10,966 - $17,290	402 Added 1.79%	22,893 $863,000
Q1 2020 May 04, 2020	BUY	$23.08 - $35.53 $472,932 - $728,045	20,491 Added 1024.55%	22,491 $670,000
Q4 2019 Feb 06, 2020	SELL	$15.74 - $35.04 $318,971 - $710,085	-20,265 Reduced 91.02%	2,000 $69,000
Q4 2019 Feb 04, 2020	BUY	$15.74 - $35.04 $307,921 - $685,487	19,563 Added 724.02%	22,265 $687,000
Q3 2019 Nov 12, 2019	BUY	$18.09 - $27.92 $48,879 - $75,439	2,702 New	2,702 $49,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.